Back
Cognition Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
CGTX
Cognition Therapeutics, Inc.
Last Price:
$1.54
Seasonality Move:
24.89%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cognition Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Sell |
| 20-day SMA: | 1.62 | Sell |
| 50-day SMA: | 1.65 | Sell |
| 200-day SMA: | 1.05 | Buy |
| 8-day EMA: | 1.56 | Sell |
| 20-day EMA: | 1.6 | Sell |
| 50-day EMA: | 1.61 | Sell |
| 200-day EMA: | 1.28 | Buy |
Cognition Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 46.08 | Sell |
| Chaikin Money Flow: | 827433 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.47 - 1.71) | Sell |
| Bollinger Bands (100): | (1.19 - 2.17) | Sell |
Cognition Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cognition Therapeutics, Inc. Stock
Is Cognition Therapeutics, Inc. Stock a Buy?
-
Cognition Therapeutics, Inc. share price is 1.54 while CGTX 8-day simple moving average is 1.58, which is a Sell signal.
-
The stock price of CGTX is 1.54 while Cognition Therapeutics, Inc. 20-day SMA is 1.62, which makes it a Sell.
-
Cognition Therapeutics, Inc. 50-day simple moving average is 1.65 while CGTX share price is 1.54, making it a Sell technically.
-
CGTX stock price is 1.54 and Cognition Therapeutics, Inc. 200-day simple moving average is 1.05, creating a Buy signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
48
Cognition Therapeutics, Inc. (CGTX)
is a Sell
Is Cognition Therapeutics, Inc. a Buy or a Sell?
-
Cognition Therapeutics, Inc. stock is rated a SellThe current Cognition Therapeutics, Inc. [CGTX] share price is $1.54. The Score for CGTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics, Inc. Stock Info
Market Cap:
135.9M
Price in USD:
1.54
Share Volume:
1.5M
Cognition Therapeutics, Inc. 52-Week Range
52-Week High:
3.83
52-Week Low:
0.22
Sell
48
Cognition Therapeutics, Inc. (CGTX)
is a Sell
Cognition Therapeutics, Inc. Share Price Forecast
-
What is the Cognition Therapeutics, Inc. stock price today?The Cognition Therapeutics, Inc. stock price is 1.54 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics, Inc. is overvalued.
Is Cognition Therapeutics, Inc. Stock a Buy?
-
Cognition Therapeutics, Inc. share price is 1.54 while CGTX 8-day exponential moving average is 1.56, which is a Sell signal.
-
The stock price of CGTX is 1.54 while Cognition Therapeutics, Inc. 20-day EMA is 1.60, which makes it a Sell.
-
Cognition Therapeutics, Inc. 50-day exponential moving average is 1.61 while CGTX share price is 1.54, making it a Sell technically.
-
CGTX stock price is 1.54 and Cognition Therapeutics, Inc. 200-day simple moving average is 1.28, creating a Buy signal.
Fundamental Analysis of Cognition Therapeutics, Inc.
Is Cognition Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.06 per share.
Technical Analysis of Cognition Therapeutics, Inc.
Should I short Cognition Therapeutics, Inc. stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cognition Therapeutics, Inc. is a Sell
-
Cognition Therapeutics, Inc. Relative Strength Index (RSI) is 46.08, which suggest Cognition Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics, Inc. is (1.47 - 1.71), which suggest Cognition Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics, Inc. is (1.19 - 2.17), which suggest Cognition Therapeutics, Inc. is a Sell
* Cognition Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.